Top Device Companies

Beckman Coulter Gets FDA Warning Letter For Heart Test

Beckman Coulter received a warning letter from the FDA for marketing the “AccuTnI on the Access Immunoassay System” heart test without agency approval. The agency said the company was marketing the test for a heart-problems marker illegally because it had not received clearance to do so. The system is intended to detect the troponin I protein, a marker for heard ailments. The company announced in April removal of its AccutnI Troponin kits from its Unicel Dxl immunoassay system that lacked FDA approval. (Click here for more – a subscription may be required)

“FDA Warns Beckman Coulter On Marketing Of ‘AccuTnI’ Heart Test” – Wall Street Journal (7/6/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Abbott, St. Jude, Baxter, BC Turn To Foreign Sales As U.S. Lags

Abbott Laboratories, St. Jude Medical, Baxter International and Beckman Coulter are among U.S.-based makers of medical devices looking to other nations for sales expansions. The firms see sales in Brazil, China, India and Russia as possible substitutes for sales declines due to the U.S. economy. Abbott Medical Optics President James Mazzo, also chairman of the Advanced Medical Technology Association, said the global market for U.S.-made devices has widened over the past five years. St. Jude, Baxter and BC report their international sales already have outpaced domestic sales in recent quarters. (Click here for more)

“U.S. Medical Device Makers Find Faster Growth Abroad” – Reuters (3/31/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Abbott, St. Jude, Others See Greater Device Sales Abroad

Abbott Laboratories, St. Jude Medical and other medical-device makers see the immediate future for sales not in the United States where they are based, but abroad. James Mazzo, president of Abbott Medical Optics, said foreign sales have become a large part of his company’s business. Mazzo also serves as chairman of the Advanced Medical Technology Association representing the U.S. device-making industry. St. Jude, Baxter International, Beckman Coulter and other companies saw international sales outpacing U.S. sales in recent quarters, with foreign sales accounting for as much as half of total revenue for some makers. (Click here for more)

“U.S. Medical Device Makers Find Faster Growth Abroad” – Reuters (3/31/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Beckman Coulter CEO Sees Tiny Increase In Device Profits In Health Plan

Beckman Coulter’s head believes health-care reform legislation moving through Congress will lead to more sales of medical devices, not less. But Scott Garrett said the increase would be minimal and his industry is not likely to reap a windfall from the eventual changes. Overall, Garrett said at a meeting, he sees an increase of no more than 2 percent a year in sales as a result of planned changes. A final bill is expected to include about $40 billion in taxes over 10 years on device-maker profits. (Click here for more)

“Beckman Sees Tiny Health Reform Gains For Sector” – Reuters (11/9/09)

JUST PUBLISHED: Medical Device Market 2009: Interventional Cardiology - Find out who’s going beyond catheters and drug-eluting stents in this vibrant space with this 86-page Special Report previously published in IN VIVO: The Business & Medicine Report. Order yours now!

 

Deals Shaping the Medical Industry (03/2009)

Article preview from IN VIVO - March 2009

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.

Deals Update

Article preview from Medtech Insight - March 2009

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Good Chemistry? Beckman Will Acquire Olympus Diagnostics For $800 Mil.

Article preview from "The Gray Sheet" - March 2, 2009

Beckman Coulter's proposed $800 million acquisition of Tokyo-based Olympus Diagnostics would help grow its chemistry diagnostics portfolio and expand its global presence, the firm said Feb. 27.

Beckman Coulter Says Japan Drag On Asian Sales

Beckman Coulter CEO Scott Garrett sees Japan, more so than the rest of Asia market, as declining for the medical device industries, leading to flat sales for his company last year. The Beckman Coulter chief said the firm did better than flat in the rest of Asia, even got a “great start” in South Korea and continued its trend of gains in the Chinese market. Still, the company reported $104.5 million in sales in the region, about the same as the year before. (Click here for more)

“Beckman Coulter Details Move To Brea, Decline In Asia” – Orange County Business Journal (2/23/09)

Looking for more information on the Asian medical device market? Try PharmAsiaNews.com.

Siemens AG Survey Shows Device Makers Not Immune To Money Crisis

Siemens: Although the health care industry usually is considered recession-proof, a Siemens AG survey suggests that is not so. The main problem, according to the survey, is that buyers of their devices, primarily hospitals, are suffering their own budget constraints. The survey showed 35 percent of institutions that buy medical devices are operating under spending freezes, affecting not only Siemens AG of Germany, but also makers such as Beckman Coulter and Toshiba America Medical Systems that operate in the United States. (Click here for more)

“Recession-Proof?” – Orange County Business Journal (2/2/09)

Looking for more insight into the medical device industry's economic outlook? IN VIVO is the premier strategic business resource for the biopharma, medtech, and diagnostics industries.

SPECIAL OFFER: Click here to get IN VIVO FREE for three months.